Published in J Vasc Res on December 18, 2012
NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells. Arterioscler Thromb Vasc Biol (2015) 1.39
Vascular Smooth Muscle Cells in Atherosclerosis. Circ Res (2016) 1.18
Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells Dev (2013) 1.01
Establishment of in vitro culture system for evaluating dentin-pulp complex regeneration with special reference to the differentiation capacity of BrdU label-retaining dental pulp cells. Histochem Cell Biol (2014) 0.90
Pericyte dynamics during angiogenesis: new insights from new identities. J Vasc Res (2014) 0.89
Nestin(+) tissue-resident multipotent stem cells contribute to tumor progression by differentiating into pericytes and smooth muscle cells resulting in blood vessel remodeling. Front Oncol (2014) 0.88
Targeting pericytes for angiogenic therapies. Microcirculation (2014) 0.84
Role of the vasa vasorum and vascular resident stem cells in atherosclerosis. Biomed Res Int (2014) 0.81
Unique remodeling processes after vascular injury in intracranial arteries: analysis using a novel mouse model. J Cereb Blood Flow Metab (2013) 0.79
Mouse aorta-derived mesenchymal progenitor cells contribute to and enhance the immune response of macrophage cells under inflammatory conditions. Stem Cell Res Ther (2015) 0.78
Immortalized multipotent pericytes derived from the vasa vasorum in the injured vasculature. A cellular tool for studies of vascular remodeling and regeneration. Lab Invest (2014) 0.78
Hedgehog and Resident Vascular Stem Cell Fate. Stem Cells Int (2015) 0.76
Scavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency. J Vasc Surg (2015) 0.75
Resveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/β-Catenin Is Protective in Vessel Graft Models. PLoS One (2015) 0.75
Adult vascular wall resident multipotent vascular stem cells, matrix metalloproteinases, and arterial aneurysms. Stem Cells Int (2015) 0.75
Pericyte-targeting drug delivery and tissue engineering. Int J Nanomedicine (2016) 0.75
Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis. Stem Cells Int (2016) 0.75
Adventitial SCA-1(+) Progenitor Cell Gene Sequencing Reveals the Mechanisms of Cell Migration in Response to Hyperlipidemia. Stem Cell Reports (2017) 0.75
Mesenchymal Stem Cell Paracrine Factors in Vascular Repair and Regeneration. J Biomed Technol Res (2014) 0.75
The myofibroblast: one function, multiple origins. Am J Pathol (2007) 8.64
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell (2005) 7.90
Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development (1999) 7.12
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol (2007) 5.50
A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res (2007) 4.34
NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn (2001) 3.71
Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest (1990) 3.15
All MSCs are pericytes? Cell Stem Cell (2008) 3.12
Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest (2004) 3.02
Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood (2004) 2.95
Pericyte physiology. FASEB J (1993) 2.88
Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res (1998) 2.78
Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation (1996) 2.77
A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol (2000) 2.70
Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol (2008) 2.68
Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ Res (2001) 2.66
The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development (2002) 2.50
Chondrogenic and adipogenic potential of microvascular pericytes. Circulation (2004) 2.48
Pericytes: cell biology and pathology. Cells Tissues Organs (2001) 2.36
Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol (2006) 2.28
Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development (2006) 2.20
Multilineage potential of cells from the artery wall. Circulation (2003) 2.17
NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell (2004) 2.14
Adventitial remodeling after coronary arterial injury. Circulation (1996) 1.94
The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture. Am J Physiol Cell Physiol (2005) 1.91
The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev (2011) 1.89
NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvasc Res (2002) 1.85
Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res (2003) 1.80
Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch (1994) 1.79
Diversity within pericytes. Clin Exp Pharmacol Physiol (2000) 1.67
The adventitia: a dynamic interface containing resident progenitor cells. Arterioscler Thromb Vasc Biol (2011) 1.58
Mesenchymal stem cells and the artery wall. Circ Res (2004) 1.52
R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis. Nat Med (2005) 1.51
Purification and culture of human blood vessel-associated progenitor cells. Curr Protoc Stem Cell Biol (2008) 1.42
FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages. Development (2008) 1.41
The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene (2008) 1.38
Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. Dev Biol (2010) 1.34
Vascular myofibroblasts. Lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol (1997) 1.30
Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. Exp Cell Res (1995) 1.22
Perivascular cells along venules upregulate NG2 expression during microvascular remodeling. Microcirculation (2006) 1.17
Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion. Glia (2001) 1.16
Perivascular cells expressing annexin A5 define a novel mesenchymal stem cell-like population with the capacity to differentiate into multiple mesenchymal lineages. Development (2005) 1.11
Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility. J Biol Chem (2004) 1.11
The adventitia: a progenitor cell niche for the vessel wall. Cells Tissues Organs (2011) 1.10
Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest Ophthalmol Vis Sci (2005) 1.08
Role of pericytes in vascular calcification: a review. Z Kardiol (2000) 1.04
Role of platelet-derived growth factors in angiogenesis and alveogenesis. Curr Top Pathol (1999) 0.95
Vascular wall resident progenitor cells: a review. Exp Cell Res (2009) 0.90
Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. J Pathol (2007) 0.89
Effects of Culturing on the Stability of the Putative Murine Adipose Derived Stem Cells Markers. Open Stem Cell J (2009) 0.85
Recurrent carotid stenosis after CEA and CAS: diagnosis and management. Semin Vasc Surg (2007) 0.85
Pathophysiology of stem cells in restenosis. Histol Histopathol (2007) 0.79
Restenosis after coronary balloon angioplasty. Annu Rev Med (1991) 0.78
A myocardial lineage derives from Tbx18 epicardial cells. Nature (2008) 6.15
NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. Mol Biol Cell (2004) 2.14
NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci (2002) 2.03
Non-stem cell origin for oligodendroglioma. Cancer Cell (2010) 1.95
Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis (2003) 1.89
NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvasc Res (2002) 1.85
Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J Clin Invest (2014) 1.82
A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell (2004) 1.73
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds. Proc Natl Acad Sci U S A (2006) 1.68
Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. Angiogenesis (2004) 1.62
Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. Cancer Cell (2012) 1.56
An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis. Angiogenesis (2007) 1.56
Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J Neurosci (2003) 1.45
FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages. Development (2008) 1.41
Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer. Cancer Res (2005) 1.38
Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. Dev Biol (2010) 1.34
Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol Biol (2002) 1.29
Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration. J Cell Biol (2007) 1.22
Epitope distance to the target cell membrane and antigen size determine the potency of T cell-mediated lysis by BiTE antibodies specific for a large melanoma surface antigen. Cancer Immunol Immunother (2010) 1.19
Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility. J Biol Chem (2004) 1.11
Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord. J Neuroinflammation (2011) 1.09
Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse. BMC Neurosci (2007) 1.07
NG2 proteoglycan mediates beta1 integrin-independent cell adhesion and spreading on collagen VI. J Cell Biochem (2002) 1.03
Differential responses of spinal axons to transection: influence of the NG2 proteoglycan. Exp Neurol (2005) 1.03
NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function. Angiogenesis (2013) 1.03
Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc Natl Acad Sci U S A (2009) 1.02
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension. J Control Release (2013) 0.97
NG2 proteoglycan expression in mouse skin: altered postnatal skin development in the NG2 null mouse. J Histochem Cytochem (2007) 0.97
Conditional ablation of the heparan sulfate-synthesizing enzyme Ext1 leads to dysregulation of bone morphogenic protein signaling and severe skeletal defects. J Biol Chem (2010) 0.97
Lymphatic/Blood endothelial cell connections at the capillary level in adult rat mesentery. Anat Rec (Hoboken) (2010) 0.95
Expression of NG2 proteoglycan during endochondral and intramembranous ossification. Dev Dyn (2003) 0.95
Engagement of the NG2 proteoglycan triggers cell spreading via rac and p130cas. Cell Signal (2003) 0.94
Promoter cloning and characterization of the anti-vascular proliferation gene, R-ras: role of Ets- and Sp-binding motifs. J Biol Chem (2008) 0.94
Collagen VI ablation retards brain tumor progression due to deficits in assembly of the vascular basal lamina. Am J Pathol (2011) 0.93
Peptide-directed highly selective targeting of pulmonary arterial hypertension. Am J Pathol (2011) 0.93
MCP-induced protein 1 suppresses TNFalpha-induced VCAM-1 expression in human endothelial cells. FEBS Lett (2010) 0.93
Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines. Histochem Cell Biol (2006) 0.92
Ablation of NG2 proteoglycan leads to deficits in brown fat function and to adult onset obesity. PLoS One (2012) 0.92
Altered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiency. Mol Cell Neurosci (2005) 0.92
Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice. Circ Res (2009) 0.92
Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan. Breast Cancer Res (2012) 0.89
Molecular basis of interaction between NG2 proteoglycan and galectin-3. J Cell Biochem (2006) 0.89
Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells. Angiogenesis (2012) 0.88
NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion. J Mol Cell Biol (2013) 0.87
Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency. Mol Pharm (2013) 0.85
Folate receptor-targeted aggregation-enhanced near-IR emitting silica nanoprobe for one-photon in vivo and two-photon ex vivo fluorescence bioimaging. Bioconjug Chem (2011) 0.85
Cell proliferation along vascular islands during microvascular network growth. BMC Physiol (2012) 0.84
Reversal of cellular roles in angiogenesis: implications for anti-angiogenic therapy. J Vasc Res (2007) 0.84
Functional and morphological effects of NG2 proteoglycan deletion on hippocampal neurogenesis. Exp Neurol (2006) 0.83
Cytolytic pathways used by effector cells derived from recipient naive and memory T cells and natural killer cells in resistance to allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2005) 0.82
Shedding of NG2 by MMP-13 attenuates anoikis. DNA Cell Biol (2014) 0.82
R-Ras Inhibits VEGF-Induced p38MAPK Activation and HSP27 Phosphorylation in Endothelial Cells. J Vasc Res (2016) 0.81
Normalization of tumor vasculature by R-Ras. Cell Cycle (2012) 0.80
Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension. Mol Pharm (2014) 0.79
Deep vascular imaging in wounds by two-photon fluorescence microscopy. PLoS One (2013) 0.78
Small molecule fluorophore and copolymer RGD peptide conjugates for ex vivo two-photon fluorescence tumor vasculature imaging. Biomaterials (2012) 0.77
Two-photon fluorescence vascular bioimaging with new bioconjugate probes selective toward the vascular endothelial growth factor receptor 2. Bioconjug Chem (2011) 0.75
TARGETING OF MACROPHAGE FOAM CELLS IN ATHEROSCLEROTIC PLAQUE USING OLIGONUCLEOTIDE-FUNCTIONALIZED NANOPARTICLES. Nano Life (2010) 0.75
Plastic casting of embryonic, placental, and tumor vasculature in the mouse. Microvasc Res (2002) 0.75
1325: HYDROCORTISONE THERAPY WITH CAR PEPTIDE PROTECTS THE INJURED ENDOTHELIAL GLYCOCALYX IN SEPSIS. Crit Care Med (2016) 0.75
Correction: Deep Vascular Imaging in Wounds by Two-Photon Fluorescence Microscopy. PLoS One (2014) 0.75